BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 25382277)

  • 1. PLS/OPLS models in metabolomics: the impact of permutation of dataset rows on the K-fold cross-validation quality parameters.
    Triba MN; Le Moyec L; Amathieu R; Goossens C; Bouchemal N; Nahon P; Rutledge DN; Savarin P
    Mol Biosyst; 2015 Jan; 11(1):13-9. PubMed ID: 25382277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tutorial review: Metabolomics and partial least squares-discriminant analysis--a marriage of convenience or a shotgun wedding.
    Gromski PS; Muhamadali H; Ellis DI; Xu Y; Correa E; Turner ML; Goodacre R
    Anal Chim Acta; 2015 Jun; 879():10-23. PubMed ID: 26002472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-linear modeling of 1H NMR metabonomic data using kernel-based orthogonal projections to latent structures optimized by simulated annealing.
    Fonville JM; Bylesjö M; Coen M; Nicholson JK; Holmes E; Lindon JC; Rantalainen M
    Anal Chim Acta; 2011 Oct; 705(1-2):72-80. PubMed ID: 21962350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-check: validation of diagnostic statistics for PLS-DA models in metabolomics studies.
    Szymańska E; Saccenti E; Smilde AK; Westerhuis JA
    Metabolomics; 2012 Jun; 8(Suppl 1):3-16. PubMed ID: 22593721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the effect of chance correlations on variable selection using Partial Least Squares-Discriminant Analysis.
    Kuligowski J; Pérez-Guaita D; Escobar J; de la Guardia M; Vento M; Ferrer A; Quintás G
    Talanta; 2013 Nov; 116():835-40. PubMed ID: 24148482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of targeted metabolomics: dominance-based rough set approach versus orthogonal partial least square-discriminant analysis.
    Blasco H; Błaszczyński J; Billaut JC; Nadal-Desbarats L; Pradat PF; Devos D; Moreau C; Andres CR; Emond P; Corcia P; Słowiński R
    J Biomed Inform; 2015 Feb; 53():291-9. PubMed ID: 25499899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCA as a practical indicator of OPLS-DA model reliability.
    Worley B; Powers R
    Curr Metabolomics; 2016; 4(2):97-103. PubMed ID: 27547730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trials and tribulations of 'omics data analysis: assessing quality of SIMCA-based multivariate models using examples from pulmonary medicine.
    Wheelock ÅM; Wheelock CE
    Mol Biosyst; 2013 Nov; 9(11):2589-96. PubMed ID: 23999822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of structurally related commercial contrast media by near infrared spectroscopy.
    Yip WL; Soosainather TC; Dyrstad K; Sande SA
    J Pharm Biomed Anal; 2014 Mar; 90():148-60. PubMed ID: 24374816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic ductal adenocarcinoma is associated with a distinct urinary metabolomic signature.
    Davis VW; Schiller DE; Eurich D; Bathe OF; Sawyer MB
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S415-23. PubMed ID: 23096698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the performance of statistical validation tools for megavariate metabolomics data.
    Rubingh CM; Bijlsma S; Derks EP; Bobeldijk I; Verheij ER; Kochhar S; Smilde AK
    Metabolomics; 2006; 2(2):53-61. PubMed ID: 24489531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLS-Based and Regularization-Based Methods for the Selection of Relevant Variables in Non-targeted Metabolomics Data.
    Bujak R; Daghir-Wojtkowiak E; Kaliszan R; Markuszewski MJ
    Front Mol Biosci; 2016; 3():35. PubMed ID: 27508208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Processing and analysis of GC/LC-MS-based metabolomics data.
    Want E; Masson P
    Methods Mol Biol; 2011; 708():277-98. PubMed ID: 21207297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of protected designation of origin for Colombian coffees based on HRMS-based metabolomics.
    Hoyos Ossa DE; Gil-Solsona R; Peñuela GA; Sancho JV; Hernández FJ
    Food Chem; 2018 Jun; 250():89-97. PubMed ID: 29412933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine.
    Carrola J; Rocha CM; Barros AS; Gil AM; Goodfellow BJ; Carreira IM; Bernardo J; Gomes A; Sousa V; Carvalho L; Duarte IF
    J Proteome Res; 2011 Jan; 10(1):221-30. PubMed ID: 21058631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of EEM fluorescence data and OPLS/UPLS-DA algorithm to discriminate between normal and cancer cell lines: a feasibility study.
    Neves AC; Fernandes de Araújo R; Luiza Cabral de Sá Leitão Oliveira A; Antunes de Araújo A; de Lima KM
    Analyst; 2014 May; 139(10):2423-31. PubMed ID: 24695676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilities for quantifying separation in PCA/PLS-DA scores plots.
    Worley B; Halouska S; Powers R
    Anal Biochem; 2013 Feb; 433(2):102-4. PubMed ID: 23079505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Discrimination of wood biological decay by NIR and partial least squares discriminant analysis (PLS-DA)].
    Yang Z; Ren HQ; Jiang ZH
    Guang Pu Xue Yu Guang Pu Fen Xi; 2008 Apr; 28(4):793-6. PubMed ID: 18619300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the statistical validity of proteomics based biomarkers.
    Smit S; van Breemen MJ; Hoefsloot HC; Smilde AK; Aerts JM; de Koster CG
    Anal Chim Acta; 2007 Jun; 592(2):210-7. PubMed ID: 17512828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of a 1H nuclear magnetic resonance (NMR) metabolomics approach combined with orthogonal projections to latent structure-discriminant analysis as an efficient tool for discriminating between Korean and Chinese herbal medicines.
    Kang J; Choi MY; Kang S; Kwon HN; Wen H; Lee CH; Park M; Wiklund S; Kim HJ; Kwon SW; Park S
    J Agric Food Chem; 2008 Dec; 56(24):11589-95. PubMed ID: 19053358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.